Kathryn Wengel
Executive Vice President, Chief Technical Operations and Risk OfficerJohnson & Johnson
PharmaceuticalsView Profile →Head of Pharmaceutical Operations and Technology · Biogen
Nicole Murphy leads pharmaceutical operations and technology at Biogen, following manufacturing and supply chain leadership at Biogen, Bioverativ and Amgen.
Last reviewed: Nov 2, 2026
Head of Pharmaceutical Operations and Technology
Biogen
Last Reviewed: November 2, 2026
Nicole Murphy leads pharmaceutical operations and technology at Biogen, following manufacturing and supply chain leadership at Biogen, Bioverativ and Amgen.
Murphy’s early career included process development and engineering positions at Monsanto and Immunex Pharmaceuticals. She worked at Amgen from 2001 to 2015 across supply chain, quality, process development, manufacturing and engineering.
At Amgen, she became executive director and head of supply chain, with responsibilities encompassing commercial manufacturing and technical operations. Her assignments included facility start-ups, business development integrations and the introduction of new products.
She joined Biogen in May 2015 as general manager and head of Cambridge site operations. During the 2017 spin-off of Biogen’s hemophilia franchise, Murphy became vice president and head of technical operations at Bioverativ. That role covered clinical and commercial development, quality, regulatory work, manufacturing and procurement.
By June 2019, Murphy was Biogen’s senior vice president and head of global manufacturing and technical operations, a position she held through January 2022. She became executive vice president of pharmaceutical operations and technology in February 2022 and joined the company’s executive committee.
Murphy holds a B.S. in engineering from the University of Massachusetts Amherst, an M.S. in engineering and an MBA from Rensselaer Polytechnic Institute.